Portfolio Detail Mitotherapeutix

Venture Portfolio

Mitotherapeutix

CEO:
Robert Hennessey

About:
Mitotherapeutix is a biopharmaceutical company with a mission to develop products for treatment of diseases that can be targeted by modifying or influencing metabolic pathways in the cell. The therapeutic goals are to disrupt or correct the metabolic processes to provide treatment solutions in cancer and degenerative liver disorders, respectively.

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio